{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:19Z","timestamp":1790959159938,"version":"4.1.0"},"reference-count":60,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2023,9,1]]},"DOI":"10.3724\/abbs.2023151","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T05:47:47Z","timestamp":1690350467000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["Metabolic signatures and potential biomarkers for the                     diagnosis and treatment of colon cancer cachexia"],"prefix":"10.3724","author":[{"given":"Xu","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"CITATION1","doi-asserted-by":"crossref","unstructured":"Jurdana M. Cancer cachexia-anorexia syndrome and skeletal muscle                         wasting.                              Radiol Oncol                                                  2009, 43: 65\u201375.","DOI":"10.2478\/v10019-009-0007-y"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/jcsm.12633","volume":"11","author":"Dolly A","year":"2020","unstructured":"Dolly A, Dumas JF, Servais S. Cancer cachexia and skeletal muscle atrophy in clinical studies:                         what do we really know?. J Cachexia Sarcopenia                             Muscle, 2020, 11: 1413-1428.","journal-title":"J Cachexia Sarcopenia                             Muscle"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"Fearon K","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A. Definition and classification of cancer cachexia: an                         international consensus. Lancet Oncol, 2011, 12: 489-495.","journal-title":"Lancet Oncol"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"Baracos VE","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers, 2018, 4:","journal-title":"Nat Rev Dis Primers"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000477157","volume":"20","author":"Sch\u00fctte M","year":"2017","unstructured":"Sch\u00fctte M, Ogilvie LA, Rieke DT, Lange BMH, Yaspo ML, Lehrach H. Cancer precision medicine: why more is more and DNA is not enough. Public Health Genomics, 2017, 20: 70-80.","journal-title":"Public Health Genomics"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","volume":"32","author":"Xiao Y","year":"2022","unstructured":"Xiao Y, Ma D, Yang YS, Yang F, Ding JH, Gong Y, Jiang L. Comprehensive metabolomics expands precision medicine for                         triple-negative breast cancer. Cell Res, 2022, 32: 477-490.","journal-title":"Cell Res"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/apm.2018.08.07","volume":"8","author":"Dev R","year":"2019","unstructured":"Dev R. Measuring cachexia-diagnostic criteria. Ann Palliat Med, 2019, 8: 24-32.","journal-title":"Ann Palliat Med"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.3390\/ijms22168491","volume":"22","author":"Nishikawa H","year":"2021","unstructured":"Nishikawa H, Goto M, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Cancer cachexia: its mechanism and clinical significance. Int J Mol Sci, 2021, 22:","journal-title":"Int J Mol Sci"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrd1157","volume":"2","author":"Nicholson JK","year":"2003","unstructured":"Nicholson JK, Wilson ID. Understanding \u2032global\u2032 systems biology: metabonomics and the                         continuum of metabolism. Nat Rev Drug Discov, 2003, 2: 668-676.","journal-title":"Nat Rev Drug Discov"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1021\/acs.analchem.6b00885","volume":"88","author":"Deng L","year":"2016","unstructured":"Deng L, Gu H, Zhu J, Nagana Gowda GA, Djukovic D, Chiorean EG, Raftery D. Combining NMR and LC\/MS using backward variable elimination:                         metabolomics analysis of colorectal cancer, polyps, and healthy controls. Anal Chem, 2016, 88: 7975-7983.","journal-title":"Anal Chem"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5009\/gnl17556","volume":"13","author":"Kwon HJ","year":"2019","unstructured":"Kwon HJ, Park MI, Park SJ, Moon W, Kim SE, Kim JH, Choi YJ. Insulin resistance is associated with early gastric cancer: a                         prospective multicenter case control study. Gut Liver, 2019, 13: 154-160.","journal-title":"Gut Liver"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1007\/s00216-020-02807-1","volume":"412","author":"Nizio\u0142 J","year":"2020","unstructured":"Nizio\u0142 J, Ossoli\u0144ski K, Tripet BP, Copi\u00e9 V, Arendowski A, Ruman T. Nuclear magnetic resonance and surface-assisted laser                         desorption\/ionization mass spectrometry-based serum metabolomics of kidney                         cancer. Anal Bioanal                             Chem, 2020, 412: 5827-5841.","journal-title":"Anal Bioanal                             Chem"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"26402","DOI":"10.1021\/acsomega.0c02600","volume":"5","author":"Zhang S","year":"2020","unstructured":"Zhang S, Lu X, Hu C, Li Y, Yang H, Yan H, Fan J. Serum metabolomics for biomarker screening of esophageal squamous                         cell carcinoma and esophageal squamous dysplasia using gas                         chromatography-mass spectrometry. ACS Omega, 2020, 5: 26402-26412.","journal-title":"ACS Omega"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.metabol.2014.07.006","volume":"63","author":"Shin HY","year":"2014","unstructured":"Shin HY, Jung KJ, Linton JA, Jee SH. Association between fasting serum glucose levels and incidence of                         colorectal cancer in Korean men: The Korean Cancer Prevention Study-II. Metabolism, 2014, 63: 1250-1256.","journal-title":"Metabolism"},{"key":"CITATION15","doi-asserted-by":"crossref","unstructured":"Nishiumi S, Kobayashi T, Ikeda A, Yoshie T, Kibi M, Izumi Y,                         Okuno T, et al. A novel serum metabolomics-based diagnostic                         approach for colorectal cancer.                              PLoS One                                                  2012, 7: e40459.","DOI":"10.1371\/journal.pone.0040459"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"17115","DOI":"10.18632\/oncotarget.15081","volume":"8","author":"Nishiumi S","year":"2017","unstructured":"Nishiumi S, Kobayashi T, Kawana S, Unno Y, Sakai T, Okamoto K, Yamada Y. Investigations in the possibility of early detection of                         colorectal cancer by gas chromatography\/triple-quadrupole mass spectrometry. Oncotarget, 2017, 8: 17115-17126.","journal-title":"Oncotarget"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jcsm.12246","volume":"9","author":"Yang QJ","year":"2018","unstructured":"Yang QJ, Zhao JR, Hao J, Li B, Huo Y, Han YL, Wan LL. Serum and urine metabolomics study reveals a distinct diagnostic                         model for cancer cachexia. J Cachexia Sarcopenia                             Muscle, 2018, 9: 71-85.","journal-title":"J Cachexia Sarcopenia                             Muscle"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13395-021-00274-5","volume":"11","author":"Zhou L","year":"2021","unstructured":"Zhou L, Zhang T, Shao W, Lu R, Wang L, Liu H, Jiang B. Amiloride ameliorates muscle wasting in cancer cachexia through                         inhibiting tumor-derived exosome release. Skeletal Muscle, 2021, 11:","journal-title":"Skeletal Muscle"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1021\/acs.jproteome.9b00088","volume":"18","author":"Cui P","year":"2019","unstructured":"Cui P, Huang C, Guo J, Wang Q, Liu Z, Zhuo H, Lin D. Metabolic profiling of tumors, sera, and skeletal muscles from an                         orthotopic murine model of gastric cancer associated-cachexia. J Proteome                             Res, 2019, 18: 1880-1892.","journal-title":"J Proteome                             Res"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3390\/molecules26071841","volume":"26","author":"Li Y","year":"2021","unstructured":"Li Y, Li X, Gao Y, Huang C, Lin D. NMR-based metabolomic analysis for the effects of \u03b1-ketoglutarate                         supplementation on C2C12 myoblasts in different energy states. Molecules, 2021, 26:","journal-title":"Molecules"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"685362","DOI":"10.3389\/fmolb.2021.685362","volume":"8","author":"Zhou L","year":"2021","unstructured":"Zhou L, Lu R, Huang C, Lin D. Taurine protects C2C12 myoblasts from impaired cell proliferation                         and myotube differentiation under cisplatin-induced ROS exposure. Front Mol Biosci, 2021, 8:","journal-title":"Front Mol Biosci"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/abbs\/gmx043","volume":"49","author":"Xu W","year":"2017","unstructured":"Xu W, Lin D, Huang C. NMR-based metabolomic analysis for the effects of creatine                         supplementation on mouse myoblast cell line C2C12. Acta Biochim Biophys                             Sin, 2017, 49: 617-627.","journal-title":"Acta Biochim Biophys                             Sin"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"Tisdale MJ","year":"2009","unstructured":"Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev, 2009, 89: 381-410.","journal-title":"Physiol Rev"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tem.2012.10.006","volume":"24","author":"Tsoli M","year":"2013","unstructured":"Tsoli M, Robertson G. Cancer cachexia: malignant inflammation, tumorkines, and                         metabolic mayhem. Trends                             Endocrinol Metab, 2013, 24: 174-183.","journal-title":"Trends                             Endocrinol Metab"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"e47258","DOI":"10.15252\/embr.201847258","volume":"20","author":"Rohm M","year":"2019","unstructured":"Rohm M, Zeigerer A, Machado J, Herzig S. Energy metabolism in cachexia. EMBO Rep, 2019, 20:","journal-title":"EMBO Rep"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/MCO.0000000000000106","volume":"17","author":"de Vos-Geelen J","year":"2014","unstructured":"de Vos-Geelen J, Fearon KCH, Schols AMW. The energy balance in cancer cachexia revisited. Curr Opin                             Clin Nutr Metab Care, 2014, 17: 509-514.","journal-title":"Curr Opin                             Clin Nutr Metab Care"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/ijms21072321","volume":"21","author":"Fonseca GWP","year":"2020","unstructured":"Fonseca GWP, Farkas J, Dora E, von Haehling S, Lainscak M. Cancer cachexia and related metabolic dysfunction. Int J Mol Sci, 2020, 21:","journal-title":"Int J Mol Sci"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/nu12061543","volume":"12","author":"Poulia KA","year":"2020","unstructured":"Poulia KA, Sarantis P, Antoniadou D, Koustas E, Papadimitropoulou A, Papavassiliou AG, Karamouzis MV. Pancreatic cancer and cachexia\u2014metabolic mechanisms and novel                         insights. Nutrients, 2020, 12:","journal-title":"Nutrients"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2174\/1568009617666170330150458","volume":"17","author":"Islam RA","year":"2017","unstructured":"Islam RA, Hossain S, Chowdhury EH. Potential therapeutic targets in energy metabolism pathways of                         breast cancer. Curr                             Cancer Drug Targets, 2017, 17: 707-721.","journal-title":"Curr                             Cancer Drug Targets"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3892\/or.2020.7548","volume":"43","author":"Wang L","year":"2020","unstructured":"Wang L, Li X. Identification of an energy metabolism\u2011related gene signature in                         ovarian cancer prognosis. Oncol Rep, 2020, 43: 1755-1770.","journal-title":"Oncol Rep"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semnephrol.2019.12.002","volume":"40","author":"Wettersten HI","year":"2020","unstructured":"Wettersten HI. Reprogramming of Metabolism in Kidney Cancer. Semin                             Nephrol, 2020, 40: 2-13.","journal-title":"Semin                             Nephrol"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/ejcn.2016.96","volume":"70","author":"Purcell SA","year":"2016","unstructured":"Purcell SA, Elliott SA, Baracos VE, Chu QSC, Prado CM. Key determinants of energy expenditure in cancer and implications                         for clinical practice. Eur J Clin Nutr, 2016, 70: 1230-1238.","journal-title":"Eur J Clin Nutr"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s11306-012-0485-6","volume":"9","author":"Der-Torossian H","year":"2013","unstructured":"Der-Torossian H, Asher SA, Winnike JH, Wysong A, Yin X, Willis MS, O\u2019Connell TM. Cancer cachexia\u2019s metabolic signature in a murine model confirms                         a distinct entity. Metabolomics, 2013, 9: 730-739.","journal-title":"Metabolomics"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s11306-008-0113-7","volume":"4","author":"O\u2019Connell TM","year":"2008","unstructured":"O\u2019Connell TM, Ardeshirpour F, Asher SA, Winnike JH, Yin X, George J, Guttridge DC. Metabolomic analysis of cancer cachexia reveals distinct lipid                         and glucose alterations. Metabolomics, 2008, 4: 216-225.","journal-title":"Metabolomics"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1039\/c3mb70134d","volume":"9","author":"Quanjun Y","year":"2013","unstructured":"Quanjun Y, Genjin Y, Lili W, Bin L, Jin L, Qi Y, Yan L. Serum metabolic profiles reveal the effect of formoterol on                         cachexia in tumor-bearing mice. Mol BioSyst, 2013, 9: 3015-3025.","journal-title":"Mol BioSyst"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1172\/JCI200420174","volume":"114","author":"Acharyya S","year":"2004","unstructured":"Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, Guttridge DC. Cancer cachexia is regulated by selective targeting of skeletal                         muscle gene products. J Clin Invest, 2004, 114: 370-378.","journal-title":"J Clin Invest"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"622","DOI":"10.7326\/0003-4819-133-8-200010170-00015","volume":"133","author":"Kotler DP","year":"2000","unstructured":"Kotler DP. Cachexia. Ann                             Intern Med, 2000, 133: 622-634.","journal-title":"Ann                             Intern Med"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s13539-012-0101-7","volume":"4","author":"Der-Torossian H","year":"2013","unstructured":"Der-Torossian H, Wysong A, Shadfar S, Willis MS, McDunn J, Couch ME. Metabolic derangements in the gastrocnemius and the effect of                         Compound A therapy in a murine model of cancer cachexia. J Cachexia                             Sarcopenia Muscle, 2013, 4: 145-155.","journal-title":"J Cachexia                             Sarcopenia Muscle"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2014.12.002","volume":"27","author":"Schug ZT","year":"2015","unstructured":"Schug ZT, Peck B, Jones DT, Zhang Q, Grosskurth S, Alam IS, Goodwin LM. Acetyl-CoA synthetase 2 promotes acetate utilization and                         maintains cancer cell growth under metabolic stress. Cancer Cell, 2015, 27: 57-71.","journal-title":"Cancer Cell"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrc3899","volume":"15","author":"Alderton GK","year":"2015","unstructured":"Alderton GK. Metabolism: acetate nourishes stressed tumour cells. Nat Rev Cancer, 2015, 15:","journal-title":"Nat Rev Cancer"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/PPO.0000000000000104","volume":"21","author":"Keenan MM","year":"2015","unstructured":"Keenan MM, Chi JT. Alternative fuels for cancer cells. Cancer J, 2015, 21: 49-55.","journal-title":"Cancer J"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.celrep.2019.04.022","volume":"27","author":"Qiu J","year":"2019","unstructured":"Qiu J, Villa M, Sanin DE, Buck MD, O\u2019Sullivan D, Ching R, Matsushita M. Acetate promotes T cell effector function during glucose                         restriction. Cell Rep, 2019, 27: 2063-2074.e5.","journal-title":"Cell Rep"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.lfs.2018.11.004","volume":"215","author":"Pandey SK","year":"2018","unstructured":"Pandey SK, Yadav S, Temre MK, Singh SM. Tracking acetate through a journey of living world: evolution as                         alternative cellular fuel with potential for application in cancer                         therapeutics. Life Sci, 2018, 215: 86-95.","journal-title":"Life Sci"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.cell.2014.11.025","volume":"159","author":"Mashimo T","year":"2014","unstructured":"Mashimo T, Pichumani K, Vemireddy V, Hatanpaa KJ, Singh DK, Sirasanagandla S, Nannepaga S. Acetate is a bioenergetic substrate for human glioblastoma and                         brain metastases. Cell, 2014, 159: 1603-1614.","journal-title":"Cell"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.cell.2014.11.020","volume":"159","author":"Comerford SA","year":"2014","unstructured":"Comerford SA, Huang Z, Du X, Wang Y, Cai L, Witkiewicz AK, Walters H. Acetate dependence of tumors. Cell, 2014, 159: 1591-1602.","journal-title":"Cell"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"697408","DOI":"10.3389\/fonc.2021.697408","volume":"11","author":"Rodr\u00edguez-Enr\u00edquez S","year":"2021","unstructured":"Rodr\u00edguez-Enr\u00edquez S, Robledo-Cadena DX, Gallardo-P\u00e9rez JC, Pacheco-Vel\u00e1zquez SC, V\u00e1zquez C, Saavedra E, Vargas-Navarro JL. Acetate promotes a differential energy metabolic response in                         human HCT 116 and COLO 205 colon cancer cells impacting cancer cell growth                         and invasiveness. Front Oncol, 2021, 11:","journal-title":"Front Oncol"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1021\/acs.jproteome.7b00859","volume":"17","author":"Jiang L","year":"2018","unstructured":"Jiang L, Lee SC, Ng TC. Pharmacometabonomics analysis reveals serum formate and acetate                         potentially associated with varying response to gemcitabine-carboplatin                         chemotherapy in metastatic breast cancer patients. J Proteome                             Res, 2018, 17: 1248-1257.","journal-title":"J Proteome                             Res"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cca.2014.12.003","volume":"441","author":"Gupta A","year":"2015","unstructured":"Gupta A, Gupta S, Mahdi AA. 1H NMR-derived serum metabolomics of leukoplakia and squamous                         cell carcinoma. Clinica Chim                             Acta, 2015, 441: 47-55.","journal-title":"Clinica Chim                             Acta"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1021\/acsomega.1c06941","volume":"7","author":"Singh A","year":"2022","unstructured":"Singh A, Prakash V, Gupta N, Kumar A, Kant R, Kumar D. Serum metabolic disturbances in lung cancer investigated through                         an elaborative nmr-based serum metabolomics approach. ACS Omega, 2022, 7: 5510-5520.","journal-title":"ACS Omega"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"3491852","DOI":"10.1155\/2019\/3491852","volume":"2019","author":"Gu J","year":"2019","unstructured":"Gu J, Xiao Y, Shu D, Liang X, Hu X, Xie Y, Lin D. Metabolomics analysis in serum from patients with colorectal                         polyp and colorectal cancer by1H-NMR spectrometry. Dis Markers, 2019, 2019:","journal-title":"Dis Markers"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1476-4598-12-78","volume":"12","author":"Straus DS","year":"2013","unstructured":"Straus DS. TNF\u03b1 and IL-17 cooperatively stimulate glucose metabolism and                         growth factor production in human colorectal cancer cells. Mol Cancer, 2013, 12:","journal-title":"Mol Cancer"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1210\/edrv.21.3.0399","volume":"21","author":"Khandwala HM","year":"2000","unstructured":"Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and                         neoplastic growth. Endocrine Rev, 2000, 21: 215-244.","journal-title":"Endocrine Rev"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"875937","DOI":"10.3389\/fnut.2022.875937","volume":"9","author":"Knecht KT","year":"2022","unstructured":"Knecht KT, Stockert AL. Editorial: complementary and alternative medicine use in cancer                         patients. Front Nutr, 2022, 9:","journal-title":"Front Nutr"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-015-0128-2","volume":"3","author":"Ahn CS","year":"2015","unstructured":"Ahn CS, Metallo CM. Mitochondria as biosynthetic factories for cancer proliferation. Cancer Metab, 2015, 3:","journal-title":"Cancer Metab"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"2548S","DOI":"10.1093\/jn\/nxaa224","volume":"150","author":"Matthews DE","year":"2020","unstructured":"Matthews DE. Review of lysine metabolism with a focus on humans. J Nutr, 2020, 150: 2548S-2555S.","journal-title":"J Nutr"},{"key":"CITATION56","doi-asserted-by":"crossref","unstructured":"Zhang J, Bowers J, Liu L, Wei S, Gowda GA, Hammoud Z, Raftery D.                         Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.                              PLoS One                                                  2012, 7: e30181.","DOI":"10.1371\/journal.pone.0030181"},{"key":"CITATION57","unstructured":"Peters SJ, van Helvoort A, Kegler D, Argiles JM, Luiking YC,                         Laviano A, van Bergenhenegouwen J, et al. Dose-dependent                         effects of leucine supplementation on preservation of muscle mass in cancer                         cachectic mice.                              Oncol Rep                                                  2011, 26: 247\u2013254."},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/jcsm.12251","volume":"9","author":"Talbert EE","year":"2018","unstructured":"Talbert EE, Lewis HL, Farren MR, Ramsey ML, Chakedis JM, Rajasekera P, Haverick E. Circulating monocyte chemoattractant protein-1 (MCP-1) is                         associated with cachexia in treatment-na\u00efve pancreatic cancer patients. J Cachexia Sarcopenia                             Muscle, 2018, 9: 358-368.","journal-title":"J Cachexia Sarcopenia                             Muscle"},{"key":"CITATION59","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jcsm.12033","volume":"6","author":"Lerner L","year":"2015","unstructured":"Lerner L, Hayes TG, Tao N, Krieger B, Feng B, Wu Z, Nicoletti R. Plasma growth differentiation factor 15 is associated with weight                         loss and mortality in cancer patients. J Cachexia Sarcopenia                             Muscle, 2015, 6: 317-324.","journal-title":"J Cachexia Sarcopenia                             Muscle"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jjco\/28.1.12","volume":"28","author":"Okada S","year":"1998","unstructured":"Okada S, Okusaka T, Ishii H, Kyogoku A, Yoshimori M, Kajimura N, Yamaguchi K. Elevated serum interleukin-6 levels in patients with pancreatic                         cancer. Jpnese J Clin Oncol, 1998, 28: 12-15.","journal-title":"Jpnese J Clin Oncol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/B063820619FA468CA4683C3730823190","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2023151","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/B063820619FA468CA4683C3730823190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T02:40:47Z","timestamp":1694659247000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2023151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":60,"URL":"https:\/\/doi.org\/10.3724\/abbs.2023151","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}